Drugs for Lactose Intolerance (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 23)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Caseins |
|
Phase 4,Phase 2 |
|
|
|
2 |
|
Chelating Agents |
|
Phase 4 |
|
|
|
3 |
|
Bifidobacterium |
Nutraceutical |
Phase 4 |
|
|
|
4 |
|
Sorbitol |
Approved |
|
|
50-70-4 |
5780
|
Synonyms:
(−)-sorbitol
(-)-Sorbitol
D-(−)-sorbitol
D-glucitol
D-Glucitol
Diakarmon
D-Sorbit
D-Sorbitol
D-Sorbol
Esasorb
Foodol D 70
Glucarine
Glucitol
G-ol
Karion
Karion instant
Kyowa Powder 50M
L-Gulitol
Multitol
Neosorb
Neosorb 20/60DC
Neosorb 70/02
Neosorb 70/70
Neosorb P 20/60
Neosorb P 60
Neosorb P 60W
Nivitin
Resulax
Sionit
Sionit K
Sionite
Sionon
|
Siosan
Sorbex M
Sorbex R
Sorbex Rp
Sorbex S
Sorbex X
Sorbilande
Sorbilax
Sorbit
Sorbit D 70
Sorbit DP
Sorbit DP 50
Sorbit D-Powder
Sorbit Kyowa Powder 50M
Sorbit L 70
Sorbit S
Sorbit T 70
Sorbit W 70
Sorbit WP
Sorbit W-Powder
Sorbit W-Powder 50
Sorbite
Sorbitol F
Sorbitol FK
Sorbitol FP
Sorbitol S
Sorbitol syrup C
Sorbitur
Sorbo
Sorbogem 712
Sorbol
Sorbostyl
|
|
5 |
|
Menthol |
Approved |
|
|
2216-51-5 |
16666
|
Synonyms:
(−
(-)-(1R,3R,4S)-Menthol
(-)-menthol
()-Menthol
(-)-Menthyl alcohol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1R)-(-)-Menthol
(1r,2s,5r)-(-)-menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(L)-MENTHOL
(r)-(-)-menthol
(R)-(-)-Menthol
)-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
1-Menthol
20747-49-3
2216-51-5
2-Isopropyl-5-methylcyclohexanol
3-p-Menthol
491-02-1
4-Isopropyl-1-methylcyclohexan-3-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
5-Methyl-2-(1-methylethyl)cyclohexanol
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
Caswell No. 540
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
D-(-)-Menthol
d,l-Menthol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
d-Menthol
d-Neomenthol
D-p-Menthan-3-ol
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
|
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
Headache crystals
Hexahydrothymol
HMS1922G13
HMS2092L14
HMS502I22
HSDB 5662
HSDB 593
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
l-(-)-Menthol
L-(-)-menthol
L-(-)-Menthol
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
l-Menthol
L-menthol
L-Menthol
l-Menthol (JP15)
l-Menthol (natural)
l-Menthol (TN)
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
M0321
M0545
M2772_SIAL
Menthacamphor
Menthol
MENTHOL
--MENTHOL
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MLS002207256
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
nchembio862-comp1
NCI-C50000
Neoisomenthol
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Peppermint camphor
p-Menthan-3-ol
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
RACEMIC MENTHOL U.S.P.
rac-Menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
Spectrum_000305
SPECTRUM1503134
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
STK802468
Tra-kill tracheal mite killer
U.S.p. Menthol
U.S.P. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
|
|
6 |
|
Chromium |
Approved |
|
|
7440-47-3 |
27668
|
Synonyms:
|
7 |
|
Vitamin A |
Approved, Nutraceutical, Vet_approved |
|
|
68-26-8, 11103-57-4 |
445354
|
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
[11,12-3H]-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
alin
All Trans Retinol
All-trans retinol
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-retinol
all-trans-Retinol
All-trans-Retinol
all-trans-retinyl alcohol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-vitamin A alcohol
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
Alphalin
Alphasterol
A-Mulsal
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
AR-1L3057
A-Sol
Atars
ATAV
Avibon
A-Vi-Pel
Avita
A-Vitan
Avitol
Axerol
Axerophthol
Axerophtholum
Bentavit A
beta-Retinol
BIDD:PXR0102
Biosterol
b-Retinol
BRN 0403040
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
Chocola A
CID445354
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
Hi-A-Vita
HMS1921B04
HMS2092L13
|
HMS501I08
Homagenets Aoral
Homagenets aorl
HSDB 815
Hydrovit A
IDI1_000486
Lard Factor
LMPR01090001
LPK
LS-1578
M.V.C. 9+3
M.V.I.-12
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
Nio-A-Let
NSC 122759
NSC122759
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
retinol
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol-(cellular-retinol-binding-protein)
Retinol, all-trans- (8CI)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
Sehkraft A
SMP2_000102
SMR000112036
Solu-A
SPECTRUM1501203
Spectrum5_000993
Spectrum5_001997
ST057232
Super A
Testavol
Testavol S
Thalasphere
trans-retinol
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
tROL
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-a
Vi-Alpha
Vi-Dom-A
Vio-A
Vitamin A
Vitamin- A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin- A alcohol
Vitamin A alcohol (VAN)
Vitamin- A alcohol solution
Vitamin A cryst
Vitamin A1
Vitamin- A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
Wachstumsvitamin
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
ZINC03831417
Zinosan N
|
|
8 |
|
Calcium, Dietary |
|
|
|
|
|
9 |
|
Anti-Infective Agents |
|
|
|
|
|
10 |
|
Antimalarials |
|
|
|
|
|
11 |
|
Antiparasitic Agents |
|
|
|
|
|
12 |
|
Antiprotozoal Agents |
|
|
|
|
|
13 |
|
Renal Agents |
|
|
|
|
|
14 |
|
Sulfalene |
|
|
|
|
|
15 |
|
insulin |
|
|
|
|
|
16 |
|
Insulin, Globin Zinc |
|
|
|
|
|
17 |
|
Bilirubin |
|
|
|
635-65-4 |
5280352
|
Synonyms:
(4Z,15Z)-Bilirubin IXa
(Z,Z)-Bilirubin IXa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
|
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
Bilirubin
Bilirubin IX-alpha
Cholerythrin
Hematoidin
|
|
18 |
|
Bone Density Conservation Agents |
|
|
|
|
|
19 |
|
Retinol palmitate |
|
|
|
|
|
20 |
|
Cola |
Nutraceutical |
|
|
|
|
21 |
|
Soy Bean |
Nutraceutical |
|
|
|
|
22 |
|
alanine |
Nutraceutical |
|
|
|
|
23 |
|
retinol |
Nutraceutical |
|
|
|
|
Interventional clinical trials:
(show all 40)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance |
Completed |
NCT02636413
|
Phase 4 |
gaxilose |
2 |
Incidence of Lactose Intolerance Among Self-reported Lactose Intolerant People |
Completed |
NCT02878876
|
Phase 4 |
|
3 |
Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior |
Completed |
NCT02406469
|
Phase 4 |
|
4 |
NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants |
Completed |
NCT03219931
|
Phase 4 |
Bifidobacterium breve BR03 and Bifidobacterium breve B632;Placebos |
5 |
Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome |
Withdrawn |
NCT02190526
|
Phase 4 |
Mesalazine(asacol 800 mg);Amitriptyline;placebo like asacol;placebo like amitriptyline |
6 |
Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance |
Completed |
NCT02673749
|
Phase 2, Phase 3 |
RP-G28 |
7 |
A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia |
Completed |
NCT01145586
|
Phase 3 |
Lactase Oral Tablets |
8 |
A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI) |
Completed |
NCT01145339
|
Phase 3 |
Lactase |
9 |
Evaluation of the Efficacy of a New Infant Formula in Subjects With Cow's Milk Allergy |
Unknown status |
NCT02149134
|
Phase 2 |
|
10 |
Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance |
Completed |
NCT01113619
|
Phase 2 |
RP-G28 or placebo;RP-G28 or placebo |
11 |
Prevalence of Lactose Intolerance Following Stem Cell Transplantation |
Terminated |
NCT00247806
|
Phase 1 |
|
12 |
The Effects of Lactose Intolerance on Gastrointestinal Function and Symptoms in a Chinese Population |
Unknown status |
NCT01286597
|
|
|
13 |
Perceived Lactose Intolerance |
Completed |
NCT01331265
|
|
|
14 |
Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls |
Completed |
NCT02171403
|
|
|
15 |
Secondary Lactose Intolerance Due to Chronic Norovirus Infection |
Completed |
NCT01840891
|
|
|
16 |
The Effect of Probiotics on Lactose Intolerance |
Completed |
NCT01593800
|
|
|
17 |
β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion |
Completed |
NCT02518295
|
|
|
18 |
Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis |
Completed |
NCT00403923
|
Early Phase 1 |
|
19 |
Effects of Raw Versus Other Milk Sources on Lactose Digestion |
Completed |
NCT01129791
|
|
|
20 |
Amount of Lactose Causing Symptoms in Lactose Intolerant People |
Completed |
NCT00395954
|
Early Phase 1 |
|
21 |
Althera® Versus Nutramigen / Cow's Milk Intolerance |
Completed |
NCT01727115
|
|
|
22 |
Acid Lactase in Combination With Yoghurt Bacteria for Improvement of Lactose Digestion in Lactose Malabsorbers |
Completed |
NCT01593631
|
|
|
23 |
HYBRID: Hydrogen Breath Test in Lactose Digestion |
Completed |
NCT02703987
|
|
|
24 |
Effects of Lactose on Fecal Microflora |
Completed |
NCT00599859
|
|
|
25 |
Calcium Absorption in Postmenopausal Thai Women |
Completed |
NCT02291315
|
|
|
26 |
Colonization and Persistence of Bifidobacterium Longum |
Completed |
NCT01650753
|
|
|
27 |
Endomicroscopy, IBS and Food Intolerance |
Completed |
NCT01692613
|
|
|
28 |
Effect of Fructose on Colonic Microflora |
Completed |
NCT00775567
|
|
|
29 |
Post-exercise Recovery After Dietary Protein Ingestion in Healthy Young Men (Meat-Milk Study) |
Completed |
NCT01578590
|
|
|
30 |
Observational Study With PASCALLERG ® in Patients With Hay Fever |
Completed |
NCT01660737
|
|
|
31 |
"Functional Bowel Disorder. Investigation in General Practice" |
Completed |
NCT01153295
|
|
|
32 |
Improving Bone Health in Adolescence Through Targeted Behavioral Intervention |
Completed |
NCT02202889
|
|
|
33 |
Lactose Intolerance and Cow's Milk Protein Allergy in Non-celiac Wheat Sensitivity Patients |
Recruiting |
NCT03008252
|
|
|
34 |
Effects of A2 Milk on Gastrointestinal Function in Non-lactose Milk Intolerance |
Recruiting |
NCT03060395
|
|
|
35 |
Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies |
Recruiting |
NCT02902016
|
|
GED |
36 |
Whole Milk Intake and Cardio-metabolic Risk Factors |
Recruiting |
NCT02798718
|
|
|
37 |
Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders |
Active, not recruiting |
NCT02085889
|
|
|
38 |
Clinical Utility of Breath Tests in GI |
Not yet recruiting |
NCT03261856
|
|
|
39 |
Validation of a Home-Screening Test for Lactose Intolerance |
Suspended |
NCT00844766
|
Early Phase 1 |
|
40 |
Evaluation of Fecal Calprotectin Screening and a Gastroenterology Questionnaire for Triaging Children With Chronic Abdominal Pain and/or Diarrhea Referred to a Pediatric Gastroenterology Service |
Terminated |
NCT01866774
|
|
|
|